What does Dr. Michaël Torfs do?

Dr. Michaël Torfs is a specialist medical practice in Edegem. Private Limited, started on 4 November 2016, 1 establishment.

What is the address of Dr. Michaël Torfs?

The registered office of Dr. Michaël Torfs is located at Mechelsesteenweg 228, 2650 Edegem.

Is Dr. Michaël Torfs still active?

Yes. According to the CBE (29 September 2026) Dr. Michaël Torfs is active, legal situation “Normale toestand”, started on 4 November 2016.

Is Dr. Michaël Torfs registered on Peppol?

Yes, Dr. Michaël Torfs is registered on the Peppol network with ID 0208:0665727925.

What is the enterprise number of Dr. Michaël Torfs?

The enterprise number of Dr. Michaël Torfs is BE0665727925.

When was Dr. Michaël Torfs founded?

Dr. Michaël Torfs was founded on 4 November 2016.

Who are the directors of Dr. Michaël Torfs?

According to the 2025 annual accounts, the directors of Dr. Michaël Torfs are: Michaël Torfs.

Is Dr. Michaël Torfs a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 4 November 2016; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dr. Michaël Torfs make in 2025?

Dr. Michaël Torfs posted a profit after taxes of € 661,178 in financial year 2025.

What is the revenue of Dr. Michaël Torfs?

As a small company, Dr. Michaël Torfs is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 865,080.

How many employees does Dr. Michaël Torfs have?

According to the 2025 annual accounts, Dr. Michaël Torfs has 0 full-time equivalents (FTE).

Dr. Michaël Torfs (Private Limited) - Edegem

Dossier Dr. Michaël Torfs, printed on 29 September 2026 from databakkes.be/en/0665727925/dr-michael-torfs. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Dr. Michaël Torfs from Edegem, company number BE0665727925, closed financial year 2025 with a result of € 661,178 after tax. For that financial year Dr. Michaël Torfs recorded a gross margin of € 865,080 and equity of € 1.1 million. Compared with financial year 2024, the result moved from € 619,679 to € 661,178. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 30, 2026.

What it is worth Healthy

€ 1.1 million

▼ 43% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 661,178

▲ 7% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 1.4 million

▲ € 1.1 million vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 1.5 million paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents

Average over the fiscal year, from the social balance sheet.

Vehicles and equipment

€ 13,428

▼ 51% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

€ 13,331

▼ 50% vs 2024

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 4,313

▲ 86% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 156,935

▲ 116% vs 2024

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 650,158 Gross margin 2022: € 650,158 First fiscal year in the series	€ 675,825 Gross margin 2023: € 675,825 ▲ 4% vs 2022 (€ 650,158) Favourable step	€ 811,597 Gross margin 2024: € 811,597 ▲ 20% vs 2023 (€ 675,825) Favourable step	€ 865,080 Gross margin 2025: € 865,080 ▲ 7% vs 2024 (€ 811,597) Favourable step	▲ 7%
Profit after taxes	€ 490,019 Profit after taxes 2022: € 490,019 First fiscal year in the series	€ 496,519 Profit after taxes 2023: € 496,519 ▲ 1% vs 2022 (€ 490,019) Favourable step	€ 619,679 Profit after taxes 2024: € 619,679 ▲ 25% vs 2023 (€ 496,519) Favourable step	€ 661,178 Profit after taxes 2025: € 661,178 ▲ 7% vs 2024 (€ 619,679) Favourable step	▲ 7%
Equity	€ 1,481,371 Equity 2022: € 1,481,371 First fiscal year in the series	€ 1,311,408 Equity 2023: € 1,311,408 ▼ 11% vs 2022 (€ 1,481,371) Unfavourable step	€ 1,931,086 Equity 2024: € 1,931,086 ▲ 47% vs 2023 (€ 1,311,408) Favourable step	€ 1,101,067 Equity 2025: € 1,101,067 ▼ 43% vs 2024 (€ 1,931,086) Unfavourable step	▼ 43%
Total debts	€ 66,095 Total debts 2022: € 66,095 First fiscal year in the series	€ 90,008 Total debts 2023: € 90,008 ▲ 36% vs 2022 (€ 66,095) Unfavourable step	€ 103,923 Total debts 2024: € 103,923 ▲ 15% vs 2023 (€ 90,008) Unfavourable step	€ 1,444,124 Total debts 2025: € 1,444,124 ▲ € 1.3 million vs 2024 (€ 103,923) Unfavourable step	▲ € 1.3 million
Cash	€ 740,522 Cash 2022: € 740,522 First fiscal year in the series	€ 583,493 Cash 2023: € 583,493 ▼ 21% vs 2022 (€ 740,522) Unfavourable step	€ 270,899 Cash 2024: € 270,899 ▼ 54% vs 2023 (€ 583,493) Unfavourable step	€ 1,413,826 Cash 2025: € 1,413,826 ▲ € 1.1 million vs 2024 (€ 270,899) Favourable step	▲ € 1.1 million
Retained profit	€ 1,462,771 Retained profit 2022: € 1,462,771 First fiscal year in the series	€ 1,292,808 Retained profit 2023: € 1,292,808 ▼ 12% vs 2022 (€ 1,462,771) Unfavourable step	€ 1,912,486 Retained profit 2024: € 1,912,486 ▲ 48% vs 2023 (€ 1,292,808) Favourable step	€ 1,082,467 Retained profit 2025: € 1,082,467 ▼ 43% vs 2024 (€ 1,912,486) Unfavourable step	▼ 43%
Dividend	€ 209,485 Dividend 2022: € 209,485 First fiscal year in the series	€ 666,482 Dividend 2023: € 666,482 ▲ 218% vs 2022 (€ 209,485) Unchanged	€ 0 Dividend 2024: € 0 ▼ 100% vs 2023 (€ 666,482) Unchanged	€ 1,491,197 Dividend 2025: € 1,491,197 Unchanged (€ 0) Unchanged
Bank debt	€ 52,435 Bank debt 2022: € 52,435 First fiscal year in the series	€ 39,547 Bank debt 2023: € 39,547 ▼ 25% vs 2022 (€ 52,435) Favourable step	€ 26,513 Bank debt 2024: € 26,513 ▼ 33% vs 2023 (€ 39,547) Favourable step	€ 13,331 Bank debt 2025: € 13,331 ▼ 50% vs 2024 (€ 26,513) Favourable step	▼ 50%
Balance sheet total	€ 1,547,466 Balance sheet total 2022: € 1,547,466 First fiscal year in the series	€ 1,401,416 Balance sheet total 2023: € 1,401,416 ▼ 9% vs 2022 (€ 1,547,466) Unchanged	€ 2,035,009 Balance sheet total 2024: € 2,035,009 ▲ 45% vs 2023 (€ 1,401,416) Unchanged	€ 2,545,191 Balance sheet total 2025: € 2,545,191 ▲ 25% vs 2024 (€ 2,035,009) Unchanged	▲ 25%

Key figures of Dr. Michaël Torfs, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. Michaël Torfs?

What happened at Dr. Michaël Torfs in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 30, 2026 New annual accounts for financial year 2025: profit of € 661,178 (▲ 7% vs 2024). Source: NBB ↗
Nov 4, 2016 New establishment in Edegem. KBO
2016 Michaël Torfs became a director. NBB
Nov 4, 2016 Start of the company according to the CBE. KBO

In short

From € 490,019 profit in 2022 to € 661,178 profit in 2025.

Paid € 749,531 in corporate taxes since 2022.

Best year ever: 2025, with € 661,178 profit.

Paid out € 2.4 million in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dr. Michaël Torfs? We notify you, reason included.

Follow Dr. Michaël Torfs

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Michaël Torfs

Dr. Michaël Torfs

Behind Dr. Michaël Torfs is Michaël Torfs.

See the full network in the app

Directors

According to the 2025 annual accounts

Michaël Torfs

Director

since 2016

Establishments

Establishment units

Physical locations of this company

Registered office

Mechelsesteenweg 228

2650 Edegem

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

ELISABET

€ 442,947 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0665.727.925
VAT number: BE 0665.727.925
Registered office: Mechelsesteenweg 228, 2650 Edegem
Names & denominations: Dr. Michaël Torfs · TOMIRAD
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 4 November 2016
Peppol: Active · Active since 8 Jan 2026
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗